Heart Disease Patients May Soon Be Prescribed Farxiga

The US Food and Drug Administration has granted fast-track approval status to Farxiga despite the drug's Fournier's Gangrene and other warnings

Thursday, July 23, 2020 - Farxiga is a drug taken by those with type-2 diabetes that wish to control their blood glucose levels without having to physically inject themselves daily with insulin. AstraZeneca, the maker of Farxiga, is being sued by individuals for allegedly causing Fournier's Gangrene, the flesh-eating disease of the genitals. Without concern or a thorough examination of the ramifications of causing Fournier's Gangrene, the anti-diabetes medication has been granted the fast track to market, circumventing the costs and delays of human clinical trials by the US Food and Drug Administration to repurpose the drug to not only treat patients with type-2 diabetes but also to now treat individuals with heart disease. The specific heart ailment that the drug will now be prescribed for is called the reduced ejection fraction. Business Wire.com explains the new use for Farxiga as being: "to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction." Of course, the drug's efficacy caveat includes that doctors prescribing the medication tell patients that changing their diet and exercise routines is critical to the drug's success. Farxiga attorneys representing families and individuals nationwide and offer a free consultation with no obligation.

In addition to being warned about the potential to develop Fournier's Gangrene, a new generation of Farxiga heart disease patients should be warned of the other devastating side effects that patients have reported after taking the drug. According to BW, "FARXIGA can cause intravascular volume depletion which may manifest as symptomatic hypotension or acute transient changes in creatinine. Acute kidney injury requiring hospitalization and dialysis has been reported in patients with type 2 diabetes receiving SGLT2 inhibitors, including FARXIGA." It has also been reported that Farxiga patients have suffered death from a condition known as Ketoacidosis, or excess acid developing in the blood. Farxiga patients also report severe urinary tract infections (UTIs).

But by far the most heinous side effect of using Farxiga may be the propensity of patients to develop Fournier's Gangrene. Farxiga patients should look for the early warning signs that their genitals may be at risk. If you are taking Farxiga you should monitor your scrotum, perineum, and penis for any sign of pain, redness, and swelling, and seek immediate medical attention. The medical solution could require surgical debridement of the area surrounding the infection as well as possible disfigurement or amputation of the genitals if Fournier's Gangrene is not immediately treated. Such disfigurement was brought to the public's attention the other day when a notorious Hollywood producer in custody for rape admitted that a portion of his penis had to be amputated due to Fourniers Gangrene, leaving him with what his victims described in court as a "penis that looked more like a vagina."

If you or a loved one are taking Farxiga and have developed Fournier's Gangrene, you may wish to speak with a Fournier's Gangrene attorney to see if you can file a claim against AstraZeneca for failing to adequately warn you about the drug's unspeakable side effect.

More Recent Diabetes Drug Infection Lawsuit News:

• Diabetic Drug Farxiga Emerges As A Potential Cause of Fournier's Gangrene | 7/20/2020
• Diabetic Drug Companies Fail To Adequately Warn Patients of The Dangers of Developing Fournier's Gangrene | 7/15/2020
• A High Profile Fournier's Gangrene Victim May Serve To Increase Public Awareness | 6/25/2020
• The Flesh-Eating Disease Could Grow Exponentially in Summer of 2020 | 6/16/2020
• AstraZeneca Pharmaceutical Web Site Warns Patient About Possible Bacterial Infections | 6/5/2020
• New Fournier's Gangrene Victim Files Lawsuit Against AstraZeneca Pharmaceuticals LP | 6/3/2020
• Fornier's Gangrene is Easily Overlooked And Could be Called Complications From the Coronavirus | 5/26/2020
• Diabetic Nursing Home Patients May Be Dying From Fournier's Gangrene | 5/15/2020
• Diabetic Patients Taking SGLT2 Diabetic Drugs Could Be At Risk of Dying from COVID19 | 4/27/2020
• Fournier's Gangrene Looks Like Frostbite Except For Its Location | 4/21/2020
• Fournier's Gangrene More Likely Than Nursing Home Neglect In Patient's Death | 4/9/2020
• Nursing Homes Need To Pay Attention To Diabetic Patients Developing Fournier's Gangrene | 3/31/2020
• New Warning For SGLT2 Diabetes Drugs Include Fournier's Gangrene | 3/19/2020
• Popular Diabetic Drug Companies Are Warned To Alert Diabetic Patients of the Risks of Developing Fournier's Gangrene | 3/12/2020
• Patient's Fournier's Gangrene Can Be Mistaken For Ordinary Nursing Home Neglect | 3/5/2020
• Nursing Home Patients Taking Diabetic Medication Must Be Monitored For Fournier's Gangrene | 2/25/2020
• Simple Necrotizing Fasciitis Can Lead To Gruesome Fournier's Gangrene | 2/7/2020
• Fournier's Gangrene Can Cause Elephantitis of the Scrotum | 2/3/2020
• Diabetic Drugs Linked to Fournier's Gangrene May Treat Heart Conditions | 1/29/2020
• The Annals of Medicine Examines the Relationship Between Certain Diabetic Drugs and Fournier's Gangrene | 1/8/2020
• Diabetic Medications Can Cause Fournier's Gangrene And Other Health-Threatening Conditions | 12/31/2019
• Fournier's Gangrene Can Leave a Survivor Severely Depressed | 12/20/2019
• Woman's Cosmetic Surgery Leads to Flesh-Eating Disease of the Genitals | 12/16/2019
• Women Diagnosed With Orbital Necrotizing Fasciitis | 12/2/2019
• The Flesh-Eating Disease Has Made The News In 2019 | 11/22/2019
• Diabetic Drugs Can Weaken The Immune System Leading To Fournier's Gangrene | 11/11/2019
• SGLT-2 Drug Makers Are Being More Forthcoming About Links To Fournier's Gangrene | 10/31/2019
• Drug Marketers Are Finding Creative Applications For SGLT-2 Drugs Ignoring The Risk of Fournier's Gangrene | 10/24/2019
• Patient Contracts Flesh-Eating Disease While Giving Birth in a New York Hospital | 10/15/2019
• Weakened Immune Systems May Be The Cause of The Outbreak in Flesh-Eating Disease | 10/3/2019
• Fournier's Gangrene Stories Are One More Shocking Than Then The Last | 10/2/2019
• Sodium-Glucose Blocker Drugs and The Flesh-Eating Disease | 9/18/2019
• Diabetic Patients Are At Risk For Developing Fournier's Gangrene Mistaken as The Ordinary Flesh-Eating Disease | 9/2/2019
• SGLT2 Inhibitor Drugs Can Now Include Reducing Heart Disease on Their Labels In Europe | 8/29/2019
• Fournier's Gangrene Can Develop In Elderly Nursing Home Patients | 8/23/2019
• Elderly Diabetic Patients Are At Risk For Fournier's Gangrene | 8/7/2019
• Florida Nursing Home Death May Have Been From Fournier's Gangrene | 8/1/2019
• There is an Outbreak of The Flesh-Eating Disease Along America's Eastern Beaches | 7/23/2019
• Fournier's Gangrene Should Not Be Confused With Everyday Necrotising Fasciitis | 7/11/2019
• Johnson & Johnson Needs To Do More To Alert Diabetics of The Flesh Eating Disease Caused By Invokana | 6/28/2019
• Diabetic Patients Living in Warmers Climates Are More at Risk to Contract Fournier's Gangrene | 6/13/2019
• The Warm Water Gulf of Mexico May Be a Breeding Ground For The Flesh Eating Disease Bacteria | 6/7/2019
• Diabetic Patients in Nursing Homes Are Ground Zero For Fournier's Gangrene | 5/30/2019
• Several New Cases Of Flesh Eating Disease Have Been Recently Reported | 5/23/2019
• Cases Of Fournier's Gangrene Increases From 12 to 55 In The Latest Peer Reviewed Medical Study | 5/13/2019
• People Are Developing The Flesh-Eating Disease In Various Ways | 4/30/2019
• Most Doctors Remain Unaware of Fournier's Gangrene and May Misdiagnose Patients | 4/19/2019
• World Governments Are Expressing Concern That Certain Diabetes Drugs Can Cause Fournier's Gangrene | 4/15/2019
• Diabetic Drugs Can Have Serious Side Effects | 4/2/2019
• Necrotising Fasciitis Effects Everyone From All Walks of Life | 3/29/2019
• Cases of Fourniers Gangrene Are Steadily Increasing Around The World | 3/25/2019
• Global Warming and Climate Change May Be Contributing to Increases In Flesh Eating Diseases | 3/11/2019
• Early Warning Signs That You May Have Fournier's Gangrene or Other Flesh-Eating Disease | 3/6/2019
• Scientists Are Encouraged By Data From Flesh-Eating Disease Studies | 2/25/2019
• The Brief History of Fournier's Gangrene | 2/20/2019
• FDA and CDC Warn About Flesh-Eating Diseases | 2/18/2019
• Diabetic Drug Warnings Admit to Causing Narcotizing Fasciitis Not Fournier's Gangrene Specifically | 2/11/2019
• Fournier's Gangrene Statistics May Be Greater Than Reported | 2/5/2019
• Diabetic Patients and Others Are At Risk For Fournier's Gangrene | 1/29/2019
• Fournier's Gangrene Frequently Asked Questions | 1/23/2019
• Diabetes Drugs Must Include Fournier's Gangrene Warning | 1/18/2019
• A Nursing Home's Elderly Diabetic Population Most at Risk For Fournier's Gangrene | 1/10/2019
• Diabetic Patients Should Be Vigilant In Watching For The Symptoms Of Fournier's Gangrene, A Flesh-Eating Disease That Can Affect The Genital Region | 1/4/2019
• An Indian Man Has Died of Fournier's Gangrene in a UK Hospital | 12/31/2018
• Pictures of Fournier's Gangrene Are Grotesque and Indescribable | 12/22/2018
• A Florida Nursing Home Patient Death Could be the 13th Case of Fournier's Gangrene | 12/20/2018
• Florida Man Dies From Genital Gangrene Quite Possibly Fournier's Gangrene | 12/15/2018
• The FDA's Fournier's Gangrene Warning is Shocking Diabetes Patients | 12/12/2018
• Drug Websites Carry The Clearest Fournier's Gangrene Amputation Warnings | 12/1/2018
• Recent FDA Warning Alerts Diabetes Patients To Watch For Signs of Genital Flesh-Eating Disease | 11/21/2018
• Diabetes Drugs May Cause Flesh-Eating Disease Affecting The Genitals | 11/1/2018

Lawyers for Fournier's Gangrene

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.